key: cord-0740187-34ljq0qt authors: Hussain, Mushtaq; Jabeen, Nusrat; Amanullah, Anusha; Baig, Ayesha Ashraf; Aziz, Basma; Shabbir, Sanya; Raza, Fozia title: Structural Basis of SARS-CoV-2 Spike Protein Priming by TMPRSS2 date: 2020-04-21 journal: bioRxiv DOI: 10.1101/2020.04.21.052639 sha: 730f5f06e5d15a8cc1a81b9e4fafb7892399f052 doc_id: 740187 cord_uid: 34ljq0qt Entry of SARS-CoV-2, etiological agent of COVID-19, in the host cell is driven by the interaction of its spike protein with human ACE2 receptor and a serine protease, TMPRSS2. Although complex between SARS-CoV-2 spike protein and ACE2 has been structurally resolved, the molecular details of the SARS-CoV-2 and TMPRSS2 complex are still elusive. TMPRSS2 is responsible for priming of the viral spike protein that entails cleavage of the spike protein at two potential sites, Arg685/Ser686 and Arg815/Ser816. The present study aims to investigate the conformational details of complex between TMPRSS2 and SARS-CoV-2 spike protein, in order to discern the finer details of the priming of viral spike and to point candidate drug targets. Briefly, full length structural model of TMPRSS2 was developed and docked against the resolved structure of SARS-CoV-2 spike protein with directional restraints of both cleavage sites. The docking simulations showed that TMPRSS2 interacts with the two different loops of SARS-CoV-2 spike protein, each containing different cleavage sites. Key functional residues of TMPRSS2 (His296, Ser441 and Ser460) were found to interact with immediate flanking residues of cleavage sites of SARS-CoV-2 spike protein. Compared to the N-terminal cleavage site (Arg685/Ser686), TMPRSS2 region that interact with C-terminal cleavage site (Arg815/Ser816) of the SARS-CoV-2 spike protein was predicted as relatively more druggable. In summary, the present study provide structural characteristics of molecular complex between human TMPRSS2 and SARS-CoV-2 spike protein and points to the candidate drug targets that could further be exploited to direct structure base drug designing. The recent pandemic of COVID-19 is the third outbreak of the diseases caused by beta coronavirus in humans, following Severe Acute Respiratory Syndrome (SARS) and Middle Eastern Respiratory Syndrome (MERS) (Cui et al., 2019) . By 13th March 2020, over 1.7 million of global population has been infected with mortality rate of 21% in closed cases (WHO COVID-19 situation report-84). Genetically, etiological agent of COVID-19, SARS-CoV-2, is closely related to SARS-CoV compared to MERS-CoV (Wu et al., 2020) . Similarly, like for SARS-CoV, Angiotensin Converting Enzyme-2 (ACE2) has been identified as the primary receptor for SARS-CoV-2 spike protein (Li, 2015; Lan et al., 2020) . Whereas MERS-CoV spike protein interacts with the DiPeptidyl Peptidase 4 (DPP4) as the first site of attachment to the host cell (Li, 2015) . Spike protein of SARS-CoV-2 is 1273 amino acid long protein with two functionally distinct regions, S1 and S2, involved in the attachment and entry of the virus, respectively. SARS-CoV-2 entry in the host cell is mediated by proteolytic cleavage of its spike protein, a process dubbed as priming. Recently, human Transmembrane Protease Serine 2 (TMPRSS2) has been shown to carry out the priming of the SARS-CoV-2 spike protein by generating two distinct fragments of the viral spike protein, S1/S2 and S2' (Hoffman et al., Recently, co-crystal structure of SARS-CoV-2 spike protein complexed with ACE2 receptor has been resolved unraveling the finer details of intermolecular interactions (Lan et al., 2020) . The However, no complex structure of SARS-CoV-2 spike protein with TMPRSS2 has been resolved to date. Moreover, the molecular structure of human TMPRSS2 protein is also not known. Resultantly, structural details of intermolecular interactions between SARS-CoV-2 and TMPRSS2 are largely unknown. Although, like many other protease inhibitors (Zhang et al., 2020) , TMPRSS2 inhibitor has been suggested and/or shown to antagonize the entry of the virus into the host cells (Hoffman et al., 2020). This study aims to investigate the interaction points between TMPRSS2 and SARS-CoV-2 spike protein using an array of bioinformatic tool. The findings not only provide structure-function relationship of TMPRSS2 of humans but also predict the sites of interactions between TMPRSS2 and SARS-CoV-2 spike protein. This could lead to the development and/or directed screening of disruptor and/or inhibitor molecules. Protein sequence of human TMPRSS2 (O15393) was retrieved from UniProt and subjected to Human TMPRSS2 is 492 amino acid long protein with three functional domains: an N-terminal LDL-receptor class A domain (113-148) followed by SRCR (153-246) and finally at C-terminal peptidase S1 domain spanning from 256 to 487 amino acid ( Figure 1A) . Till now molecular structure of the protein has not been resolved and our XtalPred analysis showed the least possibility for this molecule to be crystalized, potentially due to the high percentage of coiled structure, isoelectric point and surface hydrophobicity ( Figure 1B ). This may be the reason that Therefore, we used multiple approaches to develop the full length molecular model of TMPRSS2. The finally selected refined model of TMPRSS2 has 96.32% residues within the allowed regions of Ramachandran plot, which is acceptable considering the N-terminal portion of the protein was predicted to be intrinsically disordered. Secondly, it has been demonstrated rather frequently that many of the resolved structures of the proteins such as USP7 (PDB id: 2F1Z) have more than 20% of the residues outside the allowed region in Ramachandran plot. Moreover, Gibbs Free energy values (-14212.818 KK/mol) and ProSA Z score (-6.89) both suggest structural reliability of the model ( Figure 1C;D) . Full length molecular models of TMRPSS2 has considerable structural homology with the template molecule (PDB: 1Z8G), where the deviation between the Cα back bone of model and template was found as 0.33Å ( Figure 1E ;F). All three domains, LDL-receptor class A, SRCR and peptidase S1, formed distinct structural units in the molecular model. N-terminal region and LDL-receptor class A of TMPRSS2 were found more or less unstructured ( Figure 1G ;H). Putative Ca 2+ biding residues (Asp134, His138, Asp144, Glu145 and Ile256) were found on a The entry of the SARS-CoV-2 in the host cell is driven by the proteolytic cleavage of its spike protein resulting in the formation of two fragments, S1/S2 and S2' (Hoffman et al., 2020) . The precise positioning of the proteolytic cleavage sites have been mapped by sequence comparison and found to be at the junction of Arg685/Ser686 and Arg815/Ser816. The cleavage at the later site results in the production of S1/S2 and S2' fragments, which is necessary for the viral entry (Table 1 ; Figure 2D ). Whereas, at the second cleavage site (Arg815/Ser816), out of the three residues of catalytic triad, His296 and Ser441 established hydrogen bond interactions with Pro809, Lys814 and Ser810 of the SARS-CoV-2 spike protein (Table 1 ; Figure 3D ). Ser810 also formed a hydrogen bond and hydrophobic interaction with Ser460, substrate binding site, and His296, catalytic site of TMPRSS2, respectively (Table 1 ; Figure 3D ). Since the functionally important residues of (Table 1 ). In order to explore the druggability, interacting residues of TMPRSS2 for each cleavage site of SARS-CoV-2 spike protein were assessed for the volume, area and drug score. Consistent to the molecular docking simulations, intermolecular interactions between TMPRSS2 and Arg815/Ser816 of SARS-CoV-2 spike protein appeared as a suitable target for drug designing and development ( Figure 2E -F; 3E-F). Human TMPRSS2 is a 70kDa protein, a member of large superfamily of serine protease, mainly expressed in prostate, colon, stomach, and salivary gland (Vaarala et al., 2001) . In prostate gland its expression is regulated by androgens and found overexpressed in prostate carcinoma (Afar et al., 2001) . Physiologically, the protein is important in the functioning of epithelial sodium transport (Donaldson et al., 2002) and angiogenesis (Aimes et al., 2003) . Therefore, the present study could also be advanced in relation to explore the effect of natural polymorphism found in human TMPRSS2 on priming of SARS-CoV-2 spike protein. The authors declare that they have no conflict of interest TMPRSS2 is an activating protease for respiratory parainfluenza viruses Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis Designing helical peptide inhibitors of protein-protein interactions Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium Proteinprotein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase MolProbity: all-atom structure validation for macromolecular crystallography Origin and evolution of pathogenic coronaviruses Regulation of the epithelial sodium channel by serine proteases in human airways RCSB Protein Data Bank: Enabling biomedical research and drug discovery Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells Structural Variations in Human ACE2 may Influence its Binding with SARS-CoV-2 Spike Protein Phylogenomic and structure-function relationship studies of proteins involved in EBV associated oncogenesis Defining and searching for structural motifs using DeepView/Swiss-PdbViewer Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor Receptor recognition mechanisms of coronaviruses: a decade of structural studies Structural comparison strengthens the higherorder classification of proteases related to chymotrypsin Crystal structure of the cysteine-rich domain of scavenger receptor MARCO reveals the presence of a basic and an acidic cluster that both contribute to ligand recognition Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22. 3 I-TASSER: a unified platform for automated protein structure and function prediction In silico studies on therapeutic agents for COVID-19: Drug repurposing approach Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2 Efficient multiplication of human metapneumovirus in Vero cells expressing the transmembrane serine protease TMPRSS2 A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry XtalPred: a web server for prediction of protein crystallizability Expression of transmembrane serine protease TMPRSS2 in mouse and human tissues The HADDOCK2. 2 web server: user-friendly integrative modeling of biomolecular complexes DoGSiteScorer: a web server for automatic binding site prediction, analysis and druggability assessment Comparative protein structure modeling using MODELLER WHO COVID-19 situation report-84 ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China PRODIGY: a web server for predicting the binding affinity of protein-protein complexes Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target THR941 HIS296 LYS814 GLY391 SER940 ASP338 TYR837 ARG413 GLU1072 THR341 GLY838 GLU299 ARG682 GLU299 GLN872 GLU389 GLN935 SER460 SER810 Intermolecular Electrostatic Interactions Lys300 GLU654 LYS300 GLU868 GLU299 ARG682 GLU299 ARG682 GLU388 LYS933 HIS296 ARG682 ARG413 GLU1072 Intermolecular Hydrophobic Interactions VAL278 ARG683 HIS296 SER810 VAL278 PRO793 VAL280 PRO809 LYS342 PRO812 LEU419 LYS835 CYS465 PHE817 LYS340 TYR837